These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 24091585)

  • 1. Abnormal cardiac enzymes in systemic sclerosis: a report of four patients and review of the literature.
    Vasta B; Flower V; Bucciarelli-Ducci C; Brown S; Korendowych E; McHugh NJ; Pauling JD
    Clin Rheumatol; 2014 Mar; 33(3):435-8. PubMed ID: 24091585
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiac troponin T and NT-proBNP as diagnostic and prognostic biomarkers of primary cardiac involvement and disease severity in systemic sclerosis: A prospective study.
    Bosello S; De Luca G; Berardi G; Canestrari G; de Waure C; Gabrielli FA; Di Mario C; Forni F; Gremese E; Ferraccioli G
    Eur J Intern Med; 2019 Feb; 60():46-53. PubMed ID: 30366614
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Non-invasive diagnostic and functional evaluation of cardiac and pulmonary involvement in systemic sclerosis.
    Sergiacomi G; De Nardo D; Capria A; Manenti G; Fabiano S; Borzi M; De Sanctis G; Konda D; Sperandio M; Schillaci O; Masala S; Simonetti G; Fontana L
    In Vivo; 2004; 18(2):229-35. PubMed ID: 15113051
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical and laboratory predictions of myocardial inflammation as detected by cardiac magnetic resonance imaging in patients with systemic sclerosis: A pilot study.
    Tipparot T; Foocharoen C; Mahakkanukrauh A; Suwannaroj S; Nanagara R; Pussadhamma B; Chaosuwannakit N
    Int J Rheum Dis; 2019 Dec; 22(12):2125-2133. PubMed ID: 31659856
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of myocardial fibrosis and microvascular damage in systemic sclerosis by magnetic resonance imaging and coronary angiotomography.
    Rodríguez-Reyna TS; Morelos-Guzman M; Hernández-Reyes P; Montero-Duarte K; Martínez-Reyes C; Reyes-Utrera C; Vazquez-La Madrid J; Morales-Blanhir J; Núñez-Álvarez C; Cabiedes-Contreras J
    Rheumatology (Oxford); 2015 Apr; 54(4):647-54. PubMed ID: 25239881
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiac complications of systemic sclerosis.
    Kahan A; Coghlan G; McLaughlin V
    Rheumatology (Oxford); 2009 Jun; 48 Suppl 3():iii45-8. PubMed ID: 19487224
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myocardial fibrosis detected by magnetic resonance imaging, elevated U-CRP and higher mRSS are predictors of cardiovascular complications in systemic sclerosis (SSc) patients.
    Rodríguez-Reyna TS; Rosales-Uvera SG; Kimura-Hayama E; Hernández-Reyes P; Mercado-Velázquez P; Benavides-Suárez SA; Esquinca-González A; Núñez-Álvarez CA
    Semin Arthritis Rheum; 2019 Oct; 49(2):273-278. PubMed ID: 30853116
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of N-terminal pro-brain natriuretic peptide in detecting clinically significant cardiac involvement in systemic sclerosis patients.
    Chighizola C; Meroni PL; Schreiber BE; Coghlan JG; Denton CP; Ong VH
    Clin Exp Rheumatol; 2012; 30(2 Suppl 71):S81-5. PubMed ID: 22691215
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcome measures for heart involvement in systemic sclerosis.
    Allanore Y; Meune C; Kahan A
    Rheumatology (Oxford); 2008 Oct; 47 Suppl 5():v51-3. PubMed ID: 18784146
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiac biomarkers in systemic sclerosis: contribution of high-sensitivity cardiac troponin in addition to N-terminal pro-brain natriuretic peptide.
    Avouac J; Meune C; Chenevier-Gobeaux C; Borderie D; Lefevre G; Kahan A; Allanore Y
    Arthritis Care Res (Hoboken); 2015 Jul; 67(7):1022-30. PubMed ID: 25604469
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glucocorticoid effects on myocardial performance in patients with systemic sclerosis.
    Antoniades L; Sfikakis PP; Mavrikakis M
    Clin Exp Rheumatol; 2001; 19(4):431-7. PubMed ID: 11491499
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiac magnetic resonance imaging in systemic sclerosis: a cross-sectional observational study of 52 patients.
    Hachulla AL; Launay D; Gaxotte V; de Groote P; Lamblin N; Devos P; Hatron PY; Beregi JP; Hachulla E
    Ann Rheum Dis; 2009 Dec; 68(12):1878-84. PubMed ID: 19054830
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiac troponin testing in idiopathic inflammatory myopathies and systemic sclerosis-spectrum disorders: biomarkers to distinguish between primary cardiac involvement and low-grade skeletal muscle disease activity.
    Hughes M; Lilleker JB; Herrick AL; Chinoy H
    Ann Rheum Dis; 2015 May; 74(5):795-8. PubMed ID: 25732174
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systemic sclerosis and the heart.
    Parks JL; Taylor MH; Parks LP; Silver RM
    Rheum Dis Clin North Am; 2014 Feb; 40(1):87-102. PubMed ID: 24268011
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systemic sclerosis. A clinical overview.
    Generini S; Fiori G; Moggi Pignone A; Matucci Cerinic M; Cagnoni M
    Adv Exp Med Biol; 1999; 455():73-83. PubMed ID: 10599326
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiac involvement in scleroderma.
    Deswal A; Follansbee WP
    Rheum Dis Clin North Am; 1996 Nov; 22(4):841-60. PubMed ID: 8923599
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relation of asymmetric dimethylarginine and cardiac involvement in systemıc sclerosis.
    Dağ Ş; Budulgan M; Dilek B; Batmaz I; Arıtürk Z; Nas K; Çevik R
    Acta Reumatol Port; 2014; 39(3):228-35. PubMed ID: 25326403
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Silent myocarditis in systemic sclerosis detected by cardiovascular magnetic resonance using Lake Louise criteria.
    Mavrogeni S; Koutsogeorgopoulou L; Karabela G; Stavropoulos E; Katsifis G; Raftakis J; Plastiras S; Noutsias M; Markousis-Mavrogenis G; Kolovou G
    BMC Cardiovasc Disord; 2017 Jul; 17(1):187. PubMed ID: 28716007
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Left heart disease: a frequent cause of early pulmonary hypertension in systemic sclerosis, unrelated to elevated NT-proBNP levels or overt cardiac fibrosis but associated with increased levels of MR-proANP and MR-proADM: retrospective analysis of a French Canadian cohort.
    Miller L; Chartrand S; Koenig M; Goulet JR; Rich É; Chin AS; Chartrand-Lefebvre C; Abrahamowicz M; Senécal JL; Grodzicky T
    Scand J Rheumatol; 2014; 43(4):314-23. PubMed ID: 25089008
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical and histopathological features of patients with systemic sclerosis undergoing endomyocardial biopsy.
    Mueller KA; Mueller II; Eppler D; Zuern CS; Seizer P; Kramer U; Koetter I; Roecken M; Kandolf R; Gawaz M; Geisler T; Henes JC; Klingel K
    PLoS One; 2015; 10(5):e0126707. PubMed ID: 25966025
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.